Clinical Trial Update: Genistein in trAnSthyretin recePtor Amyloid caRdiomyopathy [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial evaluating genistein for transthyretin amyloid cardiomyopathy is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Transthyretin Amyloid Cardiomyopathy

Drugs mentioned

• Genistein (genistein)

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Amyloid Cardiomyopathy | Phase 1, Phase 2 | Status: RECRUITING